Showing results (281-290 of 672) with videos related to
Sort By:
Pageof 68
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2019
The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In VivoYasmine Sebti, Lise Ferri, Mathilde Zecchin, et al.Frontiers in Molecular Neuroscience|January 2, 2023
Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosisVéronique Ferret-Sena, Carlos Capela, Ana Macedo, et al.Journal of Lipid Research|November 5, 2013
Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assemblyDeike Hesse, Katrin Radloff, Alexander Jaschke, et al.Circulation Research|December 20, 2003
PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivationMarkus Meissner, Monika Stein, Carmen Urbich, et al.Biochimica Et Biophysica Acta|July 7, 2009
A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivationTherese H Røst, Line L Haugan Moi, Kjetil Berge, et al.Circulation Research|February 12, 2015
Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventionsEric Van Belle, Antoine Rauch, André Vincentelli, et al.JHEP Reports : Innovation in Hepatology|December 21, 2023
Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLDManuel Johanns, Joel T Haas, Violetta Raverdy, et al.International Journal of Molecular Sciences|July 2, 2021
Regulation of Monocytes/Macrophages by the Renin-Angiotensin System in Diabetic Nephropathy: State of the Art and Results of a Pilot StudyClaudine Moratal, Audrey Laurain, Mourad Naïmi, et al.Circulation Research|July 29, 2008
Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemiaRoxane M Mansouri, Eric Baugé, Philippe Gervois, et al.The Journal of Clinical Investigation|February 23, 2008
ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liverPierre-Damien Denechaud, Pascale Bossard, Jean-Marc A Lobaccaro, et al.Pageof 68